Park Ha Biological Technology Company Ltd
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Park Ha Biological Technology Company Ltd
Park Ha Biological Technology Co Ltd is engaged in developing its private skincare label, direct skincare products sales and franchise alliances promotions. Its Park Ha brand focuses on providing solutions for problematic skin. The company's Operating Subsidiaries provide skincare and cosmetic products under its brand, Park Ha in China. Its Operating Subsidiaries develop its proprietary beauty products and offer complimentary after-sales beauty services in its physical stores.
Others were interested in
Frequently asked questions
To buy Park Ha Biological Technology Company Ltd stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Park Ha Biological Technology Company Ltd by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Park Ha Biological Technology Company Ltd is BYAH:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Park Ha Biological Technology Company Ltd has its primary listing on NASDAQ (Small cap). You can trade Park Ha Biological Technology Company Ltd with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Park Ha Biological Technology Company Ltd is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Park Ha Biological Technology Company Ltd as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Park Ha Biological Technology Company Ltd.